Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000816956-26-000027
Filed / recorded
Mar 4, 2026, 9:04 PM UTC
Added to OQRO
Oct 6, 2026, 10:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CONMED Corp
Issuer CIK
816956
Ticker
CNMD
Reporting person
Matthew Schabacker
Relationship
Officer
Officer title
VP GM Advanced Surgical
Security
RSUs (Restricted Stock Units)
Table
Derivative (Table II)
Transaction date
Mar 2, 2026
Transaction code
A
Shares / units
9,827
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
9,827
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.